Pancreatic Cancer Research

ResearcherOchsner Medical CenterActive in the last 2 years

Nathan M. Bolton

Matched on ORCID iD 0000-0002-7275-6005; OpenAlex author ID A5113841608. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-24-2200↗
  2. Multiagent neoadjuvant chemotherapy and tumor response are associated with improved survival in pancreatic cancer. Co-author DOI 10.1016/j.hpb.2018.08.013↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nina G. Steele · 1 shared paper, 2025 · strength 0.19
  2. Liang‐I Kang · 1 shared paper, 2025 · strength 0.19
  3. Naomi Yamamoto · 1 shared paper, 2025 · strength 0.19
  4. Stephanie Dobersch · 1 shared paper, 2025 · strength 0.19
  5. Ian M. Loveless · 1 shared paper, 2025 · strength 0.19
  6. Sita Kugel · 1 shared paper, 2025 · strength 0.19
  7. Rachael Ann Safyan · 1 shared paper, 2025 · strength 0.19
  8. Ryan C Fields · 1 shared paper, 2025 · strength 0.19
  9. Faiyaz Notta · 1 shared paper, 2025 · strength 0.19
  10. Sunil R. Hingorani · 1 shared paper, 2025 · strength 0.19
  11. Howard C. Crawford · 1 shared paper, 2025 · strength 0.19
  12. Elena Gabriela Chiorean · 1 shared paper, 2025 · strength 0.19
  13. David G DeNardo · 1 shared paper, 2025 · strength 0.19
  14. William Charles Conway · 1 shared paper, 2019 · strength 0.11
  15. John S. Bolton · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.